German MedTech company apoQlar is the developer of the FDA Class II cleared VSI HoloMedicine medical mixed reality software platform. The company utilizes AI neural networks, computer vision and 3D rendering tech to convert grayscale medical images into color-based 3D objects, viewable through the Microsoft HoloLens 2 headset. Use cases include surgical planning, remote medical consultations and proctoring. The platform also allows for anatomy visualizations for learning purposes, being integrated with Microsoft Teams for streamlined communication across the classroom.
The company is also backed by a medical board consisting of over 35 medical advisors across 15+ medical fields
Key customers and partnerships
As of January 2024, the company had over 40 hospitals and 7 medical schools using its VSI HoloMedicine platform.
Funding and financials
In July 2023, apoQlar raised an undisclosed amount in a funding round led by YZR Capital, with funding used to facilitate the scaling of the VSI HoloMedicine version 2.0, expand the company’s market presence and scale globally.
No investor data is available
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.